Skip to main content
Premium Trial:

Request an Annual Quote

Systaaq HBV Assay Receives CE Mark

NEW YORK (GenomeWeb) — Systaaq Diagnostic Products announced on Monday that it has received CE marking for its real-time PCR-based hepatitis B diagnostic.

The assay is designed to quantitate HBV DNA in serum or plasma to assist in the treatment of chronic HBV-infected patients receiving antiviral therapy, the Manassas, Virginia-based company said. Systaaq received CE marking for its RT-PCR-based hepatitis C quantitative assay in August.

"With [their] high sensitivity and specificity … these tests can play a transformative role in the way healthcare providers [diagnose] the infections at a very early stage," Danial Richardson, chairman of Systaaq's scientific advisory board, said in a statement.

Systaaq also offers qualitative PCR-based assays for HIV-1 and dengue, according to the company’s website.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.